Jerwin Wu, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Wu’s office at (408) 971-1122 to ask if they take your plan before you enroll.
California Medical Board record
Licence A38673 · Current
Licensed to practise in California · since 1982 · expires 2028-04-30 · National Taiwan University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 115 Part D prescriptions in 2020.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2020 | 115 | 27 | 0% (0) | None | $15,872 |
| 2019 | 348 | 62 | None | 6% | $53,696 |
| 2018 | 442 | 75 | 3% (14) | 8% | $106,555 |
| 2017 | 506 | 81 | 10% (49) | 11% | $98,894 |
| 2016 | 632 | 92 | 6% (39) | 14% | $112,963 |
| 2015 | 639 | 110 | 5% (33) | 19% | $133,571 |
| 2014 | 723 | 121 | 6% (41) | 21% | $138,842 |
| 2013 | 721 | 110 | 5% (37) | 24% | $108,727 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2020: 3 drugs
| Gabapentin | 11 | $853 | $78 |
| Prednisone | 11 | $358 | $33 |
| Donepezil | 14 | $128 | $9 |
2019: 13 drugs
| Dilantin | 13 | $5,918 | $455 |
| Primidone | 24 | $2,154 | $90 |
| Gabapentin | 27 | $2,122 | $79 |
| Topiramate | 21 | $945 | $45 |
| Carbidopa-Levodopa | 20 | $847 | $42 |
| Memantine | 12 | $696 | $58 |
| Pramipexole Dihydrochloride | 13 | $652 | $50 |
| Oxazepam | 20 | $593 | $30 |
| Rizatriptan | 12 | $529 | $44 |
| Donepezil | 34 | $512 | $15 |
| Levetiracetam | 16 | $357 | $22 |
| Phenobarbital | 12 | $326 | $27 |
| Sumatriptan | 12 | $245 | $20 |
2018: 14 drugs
| Dilantin | 18 | $7,797 | $433 |
| Gabapentin | 38 | $2,191 | $58 |
| Carbidopa-Levodopa | 47 | $1,893 | $40 |
| Primidone | 28 | $1,847 | $66 |
| Topiramate | 34 | $900 | $26 |
| Pramipexole Dihydrochloride | 12 | $769 | $64 |
| Carbamazepine | 14 | $575 | $41 |
| Rizatriptan | 11 | $556 | $51 |
| Donepezil | 35 | $474 | $14 |
| Phenobarbital | 13 | $352 | $27 |
| Levetiracetam | 16 | $351 | $22 |
| Sumatriptan | 14 | $244 | $17 |
| Nortriptyline | 12 | $206 | $17 |
| Tramadol | 11 | $54 | $5 |
2017: 16 drugs
| Namenda Xr | 14 | $15,288 | $1,092 |
| Rivastigmine | 16 | $7,956 | $497 |
| Dilantin | 12 | $4,396 | $366 |
| Memantine | 18 | $2,113 | $117 |
| Carbidopa-Levodopa | 46 | $1,954 | $42 |
| Primidone | 28 | $1,324 | $47 |
| Gabapentin | 28 | $1,265 | $45 |
| Topiramate | 27 | $1,026 | $38 |
| Donepezil | 41 | $841 | $21 |
| Carbamazepine | 12 | $632 | $53 |
| Levetiracetam | 19 | $485 | $26 |
| Hydrocodone-Acetaminophen | 27 | $433 | $16 |
| Phenobarbital | 13 | $322 | $25 |
| Nortriptyline | 11 | $252 | $23 |
| Tramadol | 20 | $191 | $10 |
| Sumatriptan | 12 | $117 | $10 |
2016: 16 drugs
| Namenda Xr | 24 | $18,997 | $792 |
| Rivastigmine | 21 | $9,438 | $449 |
| Exelon | 12 | $6,297 | $525 |
| Dilantin | 12 | $3,276 | $273 |
| Donepezil | 49 | $3,186 | $65 |
| Carbidopa-Levodopa | 82 | $2,337 | $28 |
| Gabapentin | 25 | $1,939 | $78 |
| Memantine | 23 | $1,829 | $80 |
| Primidone | 30 | $1,001 | $33 |
| Pramipexole Dihydrochloride | 20 | $988 | $49 |
| Topiramate | 17 | $700 | $41 |
| Levetiracetam | 31 | $697 | $22 |
| Oxazepam | 16 | $566 | $35 |
| Hydrocodone-Acetaminophen | 24 | $429 | $18 |
| Quetiapine | 23 | $429 | $19 |
| Phenobarbital | 14 | $343 | $24 |
2015: 18 drugs
| Namenda Xr | 52 | $32,639 | $628 |
| Exelon | 15 | $12,326 | $822 |
| Namenda | 12 | $8,163 | $680 |
| Donepezil | 58 | $3,935 | $68 |
| Carbidopa-Levodopa | 102 | $2,718 | $27 |
| Galantamine Hbr | 18 | $2,298 | $128 |
| Gabapentin | 38 | $2,142 | $56 |
| Voltaren | 12 | $1,665 | $139 |
| Topiramate | 16 | $904 | $56 |
| Pramipexole Dihydrochloride | 20 | $839 | $42 |
| Acetaminophen-Codeine | 12 | $811 | $68 |
| Amantadine | 13 | $778 | $60 |
| Levetiracetam | 20 | $770 | $39 |
| Primidone | 28 | $744 | $27 |
| Quetiapine | 29 | $489 | $17 |
| Hydrocodone-Acetaminophen | 17 | $385 | $23 |
| Phenobarbital | 13 | $188 | $14 |
| Lamotrigine | 11 | $71 | $6 |
2014: 16 drugs
| Namenda | 46 | $24,385 | $530 |
| Namenda Xr | 36 | $18,582 | $516 |
| Exelon | 30 | $14,652 | $488 |
| Donepezil | 78 | $7,719 | $99 |
| Carbidopa-Levodopa-Entacapone | 12 | $4,277 | $356 |
| Carbidopa-Levodopa | 92 | $4,183 | $45 |
| Gabapentin | 80 | $3,217 | $40 |
| Galantamine Hbr | 13 | $3,156 | $243 |
| Quetiapine | 25 | $2,339 | $94 |
| Levetiracetam | 18 | $1,329 | $74 |
| Amantadine | 13 | $1,262 | $97 |
| Pramipexole Dihydrochloride | 16 | $1,069 | $67 |
| Acetaminophen-Codeine | 11 | $781 | $71 |
| Hydrocodone-Acetaminophen | 28 | $687 | $25 |
| Primidone | 26 | $468 | $18 |
| Phenobarbital | 12 | $156 | $13 |
2013: 18 drugs
| Namenda | 101 | $44,535 | $441 |
| Exelon | 27 | $13,562 | $502 |
| Donepezil | 97 | $5,565 | $57 |
| Azilect | 11 | $4,687 | $426 |
| Carbidopa-Levodopa-Entacapone | 11 | $4,593 | $418 |
| Carbidopa-Levodopa | 68 | $4,558 | $67 |
| Galantamine Hbr | 14 | $3,160 | $226 |
| Gabapentin | 77 | $2,629 | $34 |
| Amantadine | 18 | $1,983 | $110 |
| Levetiracetam | 22 | $1,502 | $68 |
| Pramipexole Dihydrochloride | 19 | $1,240 | $65 |
| Quetiapine | 21 | $916 | $44 |
| Primidone | 25 | $795 | $32 |
| Tizanidine | 12 | $691 | $58 |
| Hydrocodone-Acetaminophen | 31 | $466 | $15 |
| Carbamazepine | 12 | $185 | $15 |
| Baclofen | 12 | $170 | $14 |
| Phenobarbital | 12 | $107 | $9 |
Money from drug and device companies
$1,731 in 2019
A payment is not proof that care is biased.
| Akcea Therapeutics | Tegsedi | $397 | 4 payments
|
| Novartis Pharmaceuticals | Mayzent | $340 | 3 payments
|
| Teva Pharmaceuticals USA | Ajovy | $256 | 3 payments
|
| Amgen | Aimovig | $191 | 3 payments
|
| Adamas Pharmaceuticals | Gocovri | $173 | 4 payments
|
| Alexion Pharmaceuticals | Soliris | $149 | 2 payments
|
See all 23 published payments
| Amgen | Meals · 2019-10-25 | Aimovig | $35 |
| Akcea Therapeutics | Meals · 2019-09-19 | Tegsedi | $125 |
| Novartis Pharmaceuticals | Meals · 2019-09-18 | Gilenya | $101 |
| Alexion Pharmaceuticals | Meals · 2019-08-22 | Soliris | $125 |
| Amgen | Meals · 2019-08-02 | Aimovig | $31 |
| Akcea Therapeutics | Meals · 2019-08-01 | Tegsedi | $125 |
| Akcea Therapeutics | Meals · 2019-07-19 | Tegsedi | $124 |
| Novartis Pharmaceuticals | Meals · 2019-07-16 | Mayzent | $114 |
| Novartis Pharmaceuticals | Meals · 2019-06-18 | Mayzent | $125 |
| Teva Pharmaceuticals USA | Meals · 2019-05-30 | Ajovy | $6 |
| Alexion Pharmaceuticals | Meals · 2019-05-08 | Soliris | $24 |
| Adamas Pharmaceuticals | Meals · 2019-04-19 | Gocovri | $21 |
| Adamas Pharmaceuticals | Meals · 2019-04-19 | Gocovri | $2 |
| Akcea Therapeutics | Meals · 2019-04-12 | Tegsedi | $23 |
| AbbVie | Meals · 2019-03-29 | Duopa | $24 |
| Teva Pharmaceuticals USA | Meals · 2019-03-23 | Ajovy | $125 |
| Amgen | Meals · 2019-03-14 | Aimovig | $125 |
| Teva Pharmaceuticals USA | Meals · 2019-02-23 | Ajovy | $125 |
| US WorldMeds | Meals · 2019-02-22 | Xadago | $28 |
| AngioDynamics | Meals · 2019-02-07 | None | $148 |
| Adamas Pharmaceuticals | Meals · 2019-01-25 | Gocovri | $25 |
| ACADIA Pharmaceuticals | Meals · 2019-01-18 | Nuplazid | $25 |
| Adamas Pharmaceuticals | Meals · 2019-01-15 | Gocovri | $124 |
Professional record
- NPI
- 1346238854
- Licence
- CA A38673California A38673: Current · expires 2028-04-30
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 2101 Forest Ave, Suite 134, San Jose, CA, 95128
- NPI first listed
- 2005-10-10
- NPI last updated
- 2007-11-30
This is when the NPI record was last certified, not a medical board exam.